{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T17:32:18Z","timestamp":1789061538159,"version":"build-2803163510"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T00:00:00Z","timestamp":1645056000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T00:00:00Z","timestamp":1645056000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"The Science and Technology Planning Project of Xuzhou","award":["No. KC21251"],"award-info":[{"award-number":["No. KC21251"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>To clarify the predominance of Th1 or Th2 immune responses in malignant and tuberculous pleural effusion (MPE and TPE, respectively), we performed a meta-analysis of previously published results of the levels of Th1\/Th2 cytokines associated with these two types of pleural effusion to evaluate the use of Th1\/Th2 cytokine profiles in distinguishing TPE from MPE. We searched the PubMed and EMBASE databases for studies indexed from 2000 to March 2021. We included studies that (a) diagnosed TPE and MPE based on culture or pleural tissue biopsy and that (b) compared levels of Th1\/Th2 cytokines between TPE and MPE. Pooled data based on a random-effects model or fixed-effects model and standardized mean differences (SMDs) across studies were used to compare TPE and MPE. We also performed Egger\u2019s test to assess publication bias. Of 917 identified studies, a total of 42 studies were selected for the meta-analysis.\u00a0Compared with MPE subjects, TPE subjects had a significantly\u00a0higher level of TNF-\u03b1 [2.22, (1.60\u20132.84)], an elevated level of IFN-\u03b3 [3.30, (2.57\u20134.40)] in pleural effusion, a situation where the Th1 immune response dominated. Conversely,\u00a0the levels of interleukin-4 (IL-4) and IL-10 (Th2 cytokines) were higher in the MPE subjects than in the TPE subjects, showing statistically nonsignificant tiny effects [\u22120.15, (\u22120.94 to 0.63) and \u22120.04, (\u22120.21 to 0.12), respectively]. We confirmed that TPE, a situation in which the Th1 cytokines are predominant. The slight preponderance of Th2 cytokines in MPE, which is not convincing enough to prove.<\/jats:p>","DOI":"10.1038\/s41598-022-06685-8","type":"journal-article","created":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T06:02:53Z","timestamp":1645077773000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["A meta-analysis of Th1 and Th2 cytokine profiles differentiating tuberculous from malignant pleural effusion"],"prefix":"10.1038","volume":"12","author":[{"given":"Yulin","family":"Zeng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liwei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,17]]},"reference":[{"issue":"5","key":"6685_CR1","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1590\/S1807-59322008000500012","volume":"63","author":"LMZD Aguiar","year":"2008","unstructured":"Aguiar, L. M. Z. D. et al. Malignant and tuberculous pleural effusions: Immunophenotypic cellular characterization. Clinics (Sao Paulo, Brazil) 63(5), 637\u2013644 (2008).","journal-title":"Clinics (Sao Paulo, Brazil)"},{"key":"6685_CR2","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1164\/ajrccm.165.7.2105109","volume":"165","author":"K Oshikawa","year":"2002","unstructured":"Oshikawa, K., Yanagisawa, K., Ohno, S., Tominaga, S.-I. & Sugiyama, Y. Expression of ST2 in helper T lymphocytes of malignant pleural effusions. Am. J. Respir. Crit. Care Med. 165, 1005\u20131009 (2002).","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"9","key":"6685_CR3","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/ni969","volume":"4","author":"RA Seder","year":"2003","unstructured":"Seder, R. A. & Ahmed, R. Similarities and differences in CD4+ and CD8+ effector and memory T cell generation. Nat. Immunol. 4(9), 835\u2013842 (2003).","journal-title":"Nat. Immunol."},{"issue":"1","key":"6685_CR4","doi-asserted-by":"crossref","first-page":"3260","DOI":"10.1038\/s41598-019-40078-8","volume":"9","author":"HL Lee","year":"2019","unstructured":"Lee, H. L. et al. Inflammatory cytokines and change of Th1\/Th2 balance as prognostic indicators for hepatocellular carcinoma in patients treated with transarterial chemoembolization. Sci. Rep. 9(1), 3260 (2019).","journal-title":"Sci. Rep."},{"key":"6685_CR5","doi-asserted-by":"crossref","unstructured":"Choy, E. & Rose-John, S. Interleukin-6 as a multifunctional regulator: Inflammation, immune response, and fibrosis. J. Scleroderma Relat. Disord. 2(2), 1\u20135 (2017).","DOI":"10.5301\/jsrd.5000265"},{"issue":"2","key":"6685_CR6","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1186\/ar1917","volume":"8","author":"C Gabay","year":"2006","unstructured":"Gabay, C. Interleukin-6 and chronic inflammation. Arthritis Res. Ther. 8(2), S3 (2006).","journal-title":"Arthritis Res. Ther."},{"issue":"9","key":"6685_CR7","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0161-5890(02)00210-9","volume":"39","author":"S Diehl","year":"2002","unstructured":"Diehl, S. & Rinc\u00f3n, M. The two faces of IL-6 on Th1\/Th2 differentiation. Mol. Immunol. 39(9), 531\u2013536 (2002).","journal-title":"Mol. Immunol."},{"issue":"3","key":"6685_CR8","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/mi.2011.14","volume":"4","author":"JL Flynn","year":"2011","unstructured":"Flynn, J. L., Chan, J. & Lin, P. L. Macrophages and control of granulomatous inflammation in tuberculosis. Mucosal Immunol. 4(3), 271\u2013278 (2011).","journal-title":"Mucosal Immunol."},{"issue":"6","key":"6685_CR9","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.tube.2004.05.001","volume":"84","author":"X Bai","year":"2004","unstructured":"Bai, X., Wilson, S. E., Chmura, K., Feldman, N. E. & Chan, E. D. Morphometric analysis of Th1 and Th2 cytokine expression in human pulmonary tuberculosis. Tuberculosis 84(6), 375\u2013385 (2004).","journal-title":"Tuberculosis"},{"issue":"4","key":"6685_CR10","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1128\/CMR.9.4.532","volume":"9","author":"DR Lucey","year":"1996","unstructured":"Lucey, D. R., Clerici, M. & Shearer, G. M. Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases. Clin. Microbiol. Rev. 9(4), 532\u2013562 (1996).","journal-title":"Clin. Microbiol. Rev."},{"issue":"1","key":"6685_CR11","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0169-5002(00)00165-3","volume":"31","author":"Y-M Chen","year":"2001","unstructured":"Chen, Y.-M., Yang, W.-K., Whang-Peng, J., Tsai, C.-M. & Perng, R.-P. An analysis of cytokine status in the serum and effusions of patients with tuberculous and lung cancer. Lung Cancer 31(1), 25\u201330 (2001).","journal-title":"Lung Cancer"},{"issue":"1","key":"6685_CR12","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.lungcan.2013.07.007","volume":"82","author":"EA Lieser","year":"2013","unstructured":"Lieser, E. A. et al. Up-regulation of pro-angiogenic factors and establishment of tolerance in malignant pleural effusions. Lung Cancer 82(1), 63\u201368 (2013).","journal-title":"Lung Cancer"},{"issue":"4","key":"6685_CR13","first-page":"195","volume":"8","author":"MA Ghayumi","year":"2011","unstructured":"Ghayumi, M. A., Mojtahedi, Z. & Fattahi, M. J. Th1 and Th2 cytokine profiles in malignant pleural effusion. Iran. J. Immunol. 8(4), 195\u2013200 (2011).","journal-title":"Iran. J. Immunol."},{"key":"6685_CR14","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page, M. J. et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ 372, 71 (2021).","journal-title":"BMJ"},{"issue":"1","key":"6685_CR15","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2288-5-13","volume":"5","author":"SP Hozo","year":"2005","unstructured":"Hozo, S. P., Djulbegovic, B. & Hozo, I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med. Res. Methodol. 5(1), 13 (2005).","journal-title":"BMC Med. Res. Methodol."},{"issue":"5","key":"6685_CR16","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1042\/CS20030115","volume":"105","author":"C Alem\u00e1n","year":"2003","unstructured":"Alem\u00e1n, C. et al. Association between inflammatory mediators and the fibrinolysis system in infectious pleural effusions. Clin. Sci. 105(5), 601\u2013607 (2003).","journal-title":"Clin. Sci."},{"key":"6685_CR17","doi-asserted-by":"crossref","unstructured":"Ali, A. & Mohmoud, T. Differential diagnostic efficiency of T cells subsets versus interferon-gamma, tumor necrosis factor-alpha, and adenosine deaminase in distinguishing tuberculous from malignant pleural effusions. Chest 148(4), 68 (2015).","DOI":"10.1378\/chest.2241487"},{"issue":"4","key":"6685_CR18","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S0377-1237(11)60080-4","volume":"67","author":"V Ambade","year":"2011","unstructured":"Ambade, V., Arora, M. M., Rai, S. P., Nikumb, S. K. & Basannar, D. R. Markers for differentiation of tubercular pleural effusion from non-tubercular effusion. Med. J. Armed Forces India 67(4), 338\u2013342 (2011).","journal-title":"Med. J. Armed Forces India"},{"key":"6685_CR19","doi-asserted-by":"crossref","unstructured":"Atef, H.M., Okab, A.A., Al Mehy, G.F. & El Beheisy, M.M. The role of tumor necrosis factor alpha in differentiation between malignant and non malignant pleural effusion. Egypt. J. Chest Dis. Tuberculosis 65(3), 605\u2013612 (2016).","DOI":"10.1016\/j.ejcdt.2016.02.008"},{"issue":"5","key":"6685_CR20","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s00408-008-9107-5","volume":"186","author":"F Budak","year":"2008","unstructured":"Budak, F., Uzaslan, E. K., Cang\u00fcr, S., G\u00f6ral, G. & Oral, H. B. Increased pleural soluble fas ligand (sFasL) levels in tuberculosis pleurisy and its relation with T-helper type 1 cytokines. Lung 186(5), 337\u2013343 (2008).","journal-title":"Lung"},{"issue":"19","key":"6685_CR21","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.2174\/092986710791233652","volume":"17","author":"A Ciledag","year":"2010","unstructured":"Ciledag, A. et al. The comparison of pleural fluid TNF-alpha and IL-10 levels with ADA in tuberculous pleural effusion. Curr. Med. Chem. 17(19), 2096\u20132100 (2010).","journal-title":"Curr. Med. Chem."},{"issue":"5","key":"6685_CR22","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1183\/09031936.00126306","volume":"30","author":"ZD Daniil","year":"2007","unstructured":"Daniil, Z. D. et al. Discrimination of exudative pleural effusions based on multiple biological parameters. Eur. Respir. J. 30(5), 957\u2013964 (2007).","journal-title":"Eur. Respir. J."},{"issue":"42","key":"6685_CR23","doi-asserted-by":"crossref","first-page":"e17416","DOI":"10.1097\/MD.0000000000017416","volume":"98","author":"J Gao","year":"2019","unstructured":"Gao, J., Song, L., Li, D., Peng, L. & Ding, H. Clinical value of haptoglobin and soluble CD163 testing for the differential diagnosis of tuberculous and malignant pleural effusions. Medicine 98(42), e17416 (2019).","journal-title":"Medicine"},{"issue":"1","key":"6685_CR24","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1440-1843.2003.00529.x","volume":"9","author":"EA Hamed","year":"2004","unstructured":"Hamed, E. A., El-Noweihi, A. M., Mohamed, A. Z. & Mahmoud, A. Vasoactive mediators (VEGF and TNF-alpha) in patients with malignant and tuberculous pleural effusions. Respirology 9(1), 81\u201386 (2004).","journal-title":"Respirology"},{"issue":"17","key":"6685_CR25","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1097\/00029330-200809010-00013","volume":"121","author":"LY Huang","year":"2008","unstructured":"Huang, L. Y. et al. Expression of soluble triggering receptor expression on myeloid cells-1 in pleural effusion. Chin. Med. J. 121(17), 1656\u20131661 (2008).","journal-title":"Chin. Med. J."},{"key":"6685_CR26","doi-asserted-by":"crossref","unstructured":"Iglesias S\u00e1enz, D. et al. Metalloproteinases and tissue inhibitors of metalloproteinases in exudative pleural effusions. Eur. Respir. J. 25(1), 104\u2013109 (2005).","DOI":"10.1183\/09031936.04.00010504"},{"issue":"5","key":"6685_CR27","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.rmed.2006.09.019","volume":"101","author":"TS Kiropoulos","year":"2007","unstructured":"Kiropoulos, T. S. et al. Acute phase markers for the differentiation of infectious and malignant pleural effusions. Respir. Med. 101(5), 910\u2013918 (2007).","journal-title":"Respir. Med."},{"issue":"4","key":"6685_CR28","first-page":"342","volume":"40","author":"MH Lee","year":"2010","unstructured":"Lee, M. H., Nahm, C. H. & Choi, J. W. Thrombin-antithrombin III complex, proinflammatory cytokines, and fibrinolytic indices for assessing the severity of inflammation in pleural effusions. Ann. Clin. Lab. Sci. 40(4), 342\u2013347 (2010).","journal-title":"Ann. Clin. Lab. Sci."},{"key":"6685_CR29","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/1749-8090-9-118","volume":"9","author":"M Li","year":"2014","unstructured":"Li, M. et al. Diagnostic accuracy of tumor necrosis factor-alpha, interferon-gamma, interleukin-10 and adenosine deaminase 2 in differential diagnosis between tuberculous pleural effusion and malignant pleural effusion. J. Cardiothorac. Surg. 9, 118 (2014).","journal-title":"J. Cardiothorac. Surg."},{"key":"6685_CR30","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/1496935","volume":"2020","author":"H Liu","year":"2002","unstructured":"Liu, H. et al. Diagnostic value of soluble form of mer tyrosine kinase (sMerTK) in tuberculous pleural effusion and malignant pleural effusion. BioMed. Res. Int. 2020, 1496935. https:\/\/doi.org\/10.1155\/2020\/1496935 (2020).","journal-title":"BioMed. Res. Int."},{"issue":"10","key":"6685_CR31","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1053\/rmed.2002.1364","volume":"96","author":"H Momi","year":"2002","unstructured":"Momi, H. et al. Vascular endothelial growth factor and proinflammatory cytokines in pleural effusions. Respir. Med. 96(10), 817\u2013822 (2002).","journal-title":"Respir. Med."},{"issue":"2","key":"6685_CR32","doi-asserted-by":"crossref","first-page":"e118","DOI":"10.5301\/JBM.2012.9197","volume":"27","author":"Q Qian","year":"2012","unstructured":"Qian, Q. et al. Role of monocyte chemoattractant protein-1, tumor necrosis factor-alpha and interleukin-6 in the control of malignant pleural effusion and survival in patients with primary lung adenocarcinoma. Int. J. Biol. Markers 27(2), e118\u2013e124 (2012).","journal-title":"Int. J. Biol. Markers"},{"issue":"12","key":"6685_CR33","doi-asserted-by":"crossref","first-page":"799","DOI":"10.6061\/clinics\/2014(12)02","volume":"69","author":"M Wang","year":"2014","unstructured":"Wang, M., Zhang, Z. & Wang, X. Superoxide dismutase 2 as a marker to differentiate tuberculous pleural effusions from malignant pleural effusions. Clinics (Sao Paulo) 69(12), 799\u2013803 (2014).","journal-title":"Clinics (Sao Paulo)"},{"issue":"7","key":"6685_CR34","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1053\/rmed.2001.1103","volume":"95","author":"Y Yamada","year":"2001","unstructured":"Yamada, Y. et al. Cytokines in pleural liquid for diagnosis of tuberculous pleurisy. Respir. Med. 95(7), 577\u2013581 (2001).","journal-title":"Respir. Med."},{"issue":"6","key":"6685_CR35","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1177\/147323001003800621","volume":"38","author":"HY Cui","year":"2010","unstructured":"Cui, H. Y., Zhang, Q., Su, B., Li, W. & Tang, S. J. Differential levels of cytokines and soluble fas ligand between tuberculous and malignant effusions. J. Int. Med. Res. 38(6), 2063\u20132069 (2010).","journal-title":"J. Int. Med. Res."},{"issue":"2","key":"6685_CR36","doi-asserted-by":"crossref","first-page":"122","DOI":"10.3109\/08820139.2012.736116","volume":"42","author":"L Ibrahim","year":"2013","unstructured":"Ibrahim, L., Salah, M., Rahman, A. A. E., Zeidan, A. & Ragb, M. Crucial role of CD4+CD 25+ FOXP3+ T regulatory cell, interferon-\u03b3 and interleukin-16 in malignant and tuberculous pleural effusions. Immunol. Invest. 42(2), 122\u2013136 (2013).","journal-title":"Immunol. Invest."},{"issue":"SUPPL. 6","key":"6685_CR37","first-page":"349","volume":"59","author":"R Krenke","year":"2008","unstructured":"Krenke, R. et al. Pleural fluid adenosine deaminase and interferon-gammas diagnostic tools in tuberculous pleurisy. J. Physiol. Pharmacol. 59(SUPPL. 6), 349\u2013360 (2008).","journal-title":"J. Physiol. Pharmacol."},{"issue":"1","key":"6685_CR38","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3343\/alm.2013.33.1.45","volume":"33","author":"KS Lee","year":"2013","unstructured":"Lee, K. S. et al. Association between elevated pleural interleukin-33 levels and tuberculous pleurisy. Ann. Lab. Med. 33(1), 45\u201351 (2013).","journal-title":"Ann. Lab. Med."},{"issue":"9","key":"6685_CR39","first-page":"803","volume":"62","author":"MAM Marie","year":"2013","unstructured":"Marie, M. A. M., John, J., Krishnappa, L. G., Gopalkrishnan, S. & Bindurani, S. R. Role of interleukin-6, gamma interferon and adenosine deaminase markers in management of pleural effusion patients. West Indian Med. J. 62(9), 803\u2013807 (2013).","journal-title":"West Indian Med. J."},{"issue":"6","key":"6685_CR40","doi-asserted-by":"crossref","first-page":"4030","DOI":"10.1378\/chest.128.6.4030","volume":"128","author":"M Okamoto","year":"2005","unstructured":"Okamoto, M. et al. T-helper type 1\/T-helper type 2 balance in malignant pleural effusions compared to tuberculous pleural effusions. Chest 128(6), 4030\u20134035 (2005).","journal-title":"Chest"},{"issue":"2","key":"6685_CR41","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.lab.2004.11.013","volume":"145","author":"M Okamoto","year":"2005","unstructured":"Okamoto, M. et al. Evaluation of interferon-gamma, interferon-gamma-inducing cytokines, and interferon-gamma-inducible chemokines in tuberculous pleural effusions. J. Lab Clin. Med. 145(2), 88\u201393 (2005).","journal-title":"J. Lab Clin. Med."},{"issue":"4","key":"6685_CR42","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1183\/09031936.00085008","volume":"33","author":"L Vald\u00e9s","year":"2009","unstructured":"Vald\u00e9s, L. et al. Diagnostic value of interleukin-12 p40 in tuberculous pleural effusions. Eur. Respir. J. 33(4), 816\u2013820 (2009).","journal-title":"Eur. Respir. J."},{"issue":"3","key":"6685_CR43","doi-asserted-by":"crossref","first-page":"399","DOI":"10.4187\/respcare.02749","volume":"59","author":"L Vald\u00e9s","year":"2014","unstructured":"Vald\u00e9s, L. et al. Interleukin 27 could be useful in the diagnosis of tuberculous pleural effusions. Respir. Care 59(3), 399\u2013405 (2014).","journal-title":"Respir. Care"},{"issue":"17","key":"6685_CR44","first-page":"3215","volume":"126","author":"YB Wu","year":"2013","unstructured":"Wu, Y. B. et al. Combined detections of interleukin 27, interferon-\u03b3, and adenosine deaminase in pleural effusion for diagnosis of tuberculous pleurisy. Chin. Med. J. (Engl.) 126(17), 3215\u20133221 (2013).","journal-title":"Chin. Med. J. (Engl.)"},{"issue":"5","key":"6685_CR45","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s11596-007-0504-4","volume":"27","author":"K Xue","year":"2007","unstructured":"Xue, K., Xiong, S. & Xiong, W. Clinical value of vascular endothelial growth factor combined with interferon-gamma in diagnosing malignant pleural effusion and tuberculous pleural effusion. J. Huazhong Univ. Sci. Technol. Med. Sci. 27(5), 495\u2013497 (2007).","journal-title":"J. Huazhong Univ. Sci. Technol. Med. Sci."},{"key":"6685_CR46","doi-asserted-by":"crossref","unstructured":"Yurt, S. et al. Diagnostic utility of serum and pleural levels of adenosine deaminase 1\u20132, and interferon-\u03b3 in the diagnosis of pleural tuberculosis. Multidiscip. Respir. Med. 9(1), 113 (2014).","DOI":"10.1186\/2049-6958-9-12"},{"issue":"2","key":"6685_CR47","first-page":"1871","volume":"15","author":"M Zhang","year":"2018","unstructured":"Zhang, M., Xiong, D., Li, H., Wang, Z. & Li, R. Diagnostic value of T-spot TB combined with INF-\u03b3 and IL-27 in tuberculous pleurisy. Exp. Ther. Med. 15(2), 1871\u20131874 (2018).","journal-title":"Exp. Ther. Med."},{"issue":"1","key":"6685_CR48","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/resp.12414","volume":"20","author":"CC Shu","year":"2015","unstructured":"Shu, C. C. et al. Diagnostic role of inflammatory and anti-inflammatory cytokines and effector molecules of cytotoxic T lymphocytes in tuberculous pleural effusion. Respirology 20(1), 147\u2013154 (2015).","journal-title":"Respirology"},{"issue":"4","key":"6685_CR49","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1080\/00365513.2020.1728784","volume":"80","author":"J Zhang","year":"2020","unstructured":"Zhang, J. et al. Differential diagnosis of tuberculous and malignant pleural effusions: Comparison of the Th1\/Th2 cytokine panel, tumor marker panel and chemistry panel. Scand. J. Clin. Lab. Invest. 80(4), 265\u2013270 (2020).","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"6685_CR50","doi-asserted-by":"crossref","first-page":"183","DOI":"10.2147\/IJGM.S100237","volume":"9","author":"KY Chen","year":"2016","unstructured":"Chen, K. Y. et al. Novel biomarker analysis of pleural effusion enhances differentiation of tuberculous from malignant pleural effusion. Int. J. Gen. Med. 9, 183\u2013189 (2016).","journal-title":"Int. J. Gen. Med."},{"issue":"1","key":"6685_CR51","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/s41598-020-79685-1","volume":"11","author":"RN Dalil","year":"2021","unstructured":"Dalil, R. N. et al. Potential diagnostic value of pleural fluid cytokines levels for tuberculous pleural effusion. Sci. Rep. 11(1), 660 (2021).","journal-title":"Sci. Rep."},{"issue":"2","key":"6685_CR52","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.ejcdt.2014.11.005","volume":"64","author":"R El Sayed","year":"2015","unstructured":"El Sayed, R., Okab, A., El-Mahdy, M., Kasb, I. & Ismail, Y. Role of interleukin-6 (IL-6) in diagnosis of malignant pleural mesothelioma. Egypt. J. Chest Dis. Tuberculosis 64(2), 419\u2013424 (2015).","journal-title":"Egypt. J. Chest Dis. Tuberculosis"},{"key":"6685_CR53","doi-asserted-by":"crossref","unstructured":"L. Ferreiro et al. Diagnosis of infectious pleural effusion using predictive models based on pleural fluid biomarkers. Ann. Thoracic Med. 14(4), 254\u2013263 (2019).","DOI":"10.4103\/atm.ATM_77_19"},{"issue":"6","key":"6685_CR54","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1007\/s00408-016-9945-5","volume":"194","author":"LR Teixeira","year":"2016","unstructured":"Teixeira, L. R. et al. Profile of metalloproteinases and their association with inflammatory markers in pleural effusions. Lung 194(6), 1021\u20131027 (2016).","journal-title":"Lung"},{"issue":"3","key":"6685_CR55","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1378\/chest.121.3.815","volume":"121","author":"N Xirouchaki","year":"2002","unstructured":"Xirouchaki, N. et al. Diagnostic value of interleukin-1alpha, interleukin-6, and tumor necrosis factor in pleural effusions. Chest 121(3), 815\u2013820 (2002).","journal-title":"Chest"},{"key":"6685_CR56","doi-asserted-by":"crossref","unstructured":"Liu, Y.C. et al. Differential diagnosis of tuberculous and malignant pleurisy using pleural fluid adenosine deaminase and interferon gamma in Taiwan. J. Microbiol. Immunol. Infect. 44(2), 88\u201394 (2011).","DOI":"10.1016\/j.jmii.2010.04.001"},{"key":"6685_CR57","doi-asserted-by":"crossref","first-page":"854507","DOI":"10.1155\/2015\/854507","volume":"2015","author":"IV Lyadova","year":"2015","unstructured":"Lyadova, I. V. & Panteleev, A. V. Th1 and Th17 cells in tuberculosis: Protection. Pathol. Biomarkers Mediators Inflamm. 2015, 854507\u2013854507 (2015).","journal-title":"Pathol. Biomarkers Mediators Inflamm."},{"key":"6685_CR58","doi-asserted-by":"crossref","unstructured":"Cavalcanti, Y.V.N., Brelaz, M.C.A., Neves, J.K.D.A.L., Ferraz, J.C. & Pereira, V.R.A. Role of TNF-alpha, IFN-gamma, and IL-10 in the development of pulmonary tuberculosis. Pulm. Med. 2012, 745483\u2013745483 (2012)","DOI":"10.1155\/2012\/745483"},{"issue":"1","key":"6685_CR59","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/sj.jidsymp.5650027","volume":"12","author":"PL Lin","year":"2007","unstructured":"Lin, P. L., Plessner, H. L., Voitenok, N. N. & Flynn, J. L. Tumor necrosis factor and tuberculosis. J. Invest. Dermatol. Sympos. Proceed. 12(1), 22\u201325 (2007).","journal-title":"J. Invest. Dermatol. Sympos. Proceed."},{"issue":"9","key":"6685_CR60","doi-asserted-by":"crossref","first-page":"4750","DOI":"10.4049\/jimmunol.171.9.4750","volume":"171","author":"V Nagabhushanam","year":"2003","unstructured":"Nagabhushanam, V. et al. Innate inhibition of adaptive immunity: Mycobacterium tuberculosis-induced IL-6 inhibits macrophage responses to IFN-gamma. J. Immunol. (Baltimore, Md. 1950) 171(9), 4750\u20134757 (2003).","journal-title":"J. Immunol. (Baltimore, Md. 1950)"},{"key":"6685_CR61","doi-asserted-by":"crossref","unstructured":"Diehl, S. et al. Inhibition of Th1 differentiation by IL-6 is mediated by SOCS1. Immunity 13(6), 805\u2013815 (2000).","DOI":"10.1016\/S1074-7613(00)00078-9"},{"key":"6685_CR62","doi-asserted-by":"crossref","unstructured":"Carow, B. et al. Silencing suppressor of cytokine signaling-1 (SOCS1) in macrophages improves Mycobacterium tuberculosis control in an interferon-gamma (IFN-gamma)-dependent manner. J. Biol. Chem. 286(30), 26873\u201326887 (2011)","DOI":"10.1074\/jbc.M111.238287"},{"key":"6685_CR63","doi-asserted-by":"crossref","unstructured":"Redford, P.S., Murray, P.J. & O\u2019Garra, A. The role of IL-10 in immune regulation during M. tuberculosis infection. Mucosal Immunol. 4(3), 261\u2013270 (2011).","DOI":"10.1038\/mi.2011.7"},{"issue":"3","key":"6685_CR64","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.ejcdt.2015.03.005","volume":"64","author":"AHK Ali","year":"2015","unstructured":"Ali, A. H. K., Mahmoud, T. M. & Ahmed, H. Differential diagnostic efficiency of T cells subsets versus interferon-gamma, tumor necrosis factor-alpha and adenosine deaminase in distinguishing tuberculous from malignant pleural effusions. Egypt. J. Chest Dis. Tuberculosis 64(3), 645\u2013651 (2015).","journal-title":"Egypt. J. Chest Dis. Tuberculosis"},{"issue":"2","key":"6685_CR65","doi-asserted-by":"crossref","first-page":"1802242","DOI":"10.1183\/13993003.02242-2018","volume":"54","author":"A Pooran","year":"2019","unstructured":"Pooran, A. et al. IL-4 subverts mycobacterial containment in Mycobacterium tuberculosis-infected human macrophages. Eur. Respir. J. 54(2), 1802242 (2019).","journal-title":"Eur. Respir. J."},{"issue":"2","key":"6685_CR66","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ccr.2009.06.018","volume":"16","author":"DG DeNardo","year":"2009","unstructured":"DeNardo, D. G. et al. CD4(+) T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages. Cancer Cell 16(2), 91\u2013102 (2009).","journal-title":"Cancer Cell"},{"issue":"1","key":"6685_CR67","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s12905-020-00972-0","volume":"20","author":"W Lin","year":"2020","unstructured":"Lin, W. et al. The disease stage-associated imbalance of Th1\/Th2 and Th17\/Treg in uterine cervical cancer patients and their recovery with the reduction of tumor burden. BMC Womens Health 20(1), 126 (2020).","journal-title":"BMC Womens Health"},{"issue":"3","key":"6685_CR68","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/BF00812261","volume":"21","author":"MR Shurin","year":"1999","unstructured":"Shurin, M. R., Lu, L., Kalinski, P., Stewart-Akers, A. M. & Lotze, M. T. Th1\/Th2 balance in cancer, transplantation and pregnancy. Springer Semin. Immunopathol. 21(3), 339\u2013359 (1999).","journal-title":"Springer Semin. Immunopathol."},{"issue":"5","key":"6685_CR69","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.otohns.2004.03.016","volume":"131","author":"A Sparano","year":"2004","unstructured":"Sparano, A., Lathers, D. M. R., Achille, N., Petruzzelli, G. J. & Young, M. R. I. Modulation of Th1 and Th2 cytokine profiles and their association with advanced head and neck squamous cell carcinoma. Otolaryngol.-Head Neck Surg. 131(5), 573\u2013576 (2004).","journal-title":"Otolaryngol.-Head Neck Surg."},{"issue":"8","key":"6685_CR70","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1158\/1078-0432.CCR-03-0239","volume":"10","author":"D Atanackovic","year":"2004","unstructured":"Atanackovic, D. et al. Characterization of effusion-infiltrating T cells. Clin. Cancer Res. 10(8), 2600 (2004).","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"6685_CR71","doi-asserted-by":"crossref","first-page":"73","DOI":"10.4049\/jimmunol.156.1.73","volume":"156","author":"H Maeda","year":"1996","unstructured":"Maeda, H. & Shiraishi, A. TGF-beta contributes to the shift toward Th2-type responses through direct and IL-10-mediated pathways in tumor-bearing mice. J. Immunol. (Baltimore, Md. 1950) 156(1), 73\u201378 (1996).","journal-title":"J. Immunol. (Baltimore, Md. 1950)"},{"issue":"7","key":"6685_CR72","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1002\/art.24632","volume":"60","author":"F Tubach","year":"2009","unstructured":"Tubach, F. et al. G. Research axed on tolerance of biotherapies, risk of tuberculosis is higher with anti-tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: The three-year prospective French Research Axed on Tolerance of Biotherapies registry. Arthritis Rheum. 60(7), 1884\u20131894 (2009).","journal-title":"Arthritis Rheum."},{"issue":"6","key":"6685_CR73","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.ccell.2019.05.005","volume":"35","author":"J Qiao","year":"2019","unstructured":"Qiao, J. et al. Targeting tumors with IL-10 prevents dendritic cell-mediated CD8+ T cell apoptosis. Cancer Cell 35(6), 901-915.e4 (2019).","journal-title":"Cancer Cell"},{"issue":"1","key":"6685_CR74","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.cyto.2015.05.026","volume":"75","author":"A Suzuki","year":"2015","unstructured":"Suzuki, A., Leland, P., Joshi, B. H. & Puri, R. K. Targeting of IL-4 and IL-13 receptors for cancer therapy. Cytokine 75(1), 79\u201388 (2015).","journal-title":"Cytokine"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-06685-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-06685-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-06685-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T16:32:06Z","timestamp":1726677126000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-06685-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,17]]},"references-count":74,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["6685"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-06685-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,17]]},"assertion":[{"value":"25 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2743"}}